Clinical characteristics of lupus myocarditis in Korea
Tóm tắt
Clinically important myocarditis is an unusual feature in systemic lupus erythematosus (SLE). We describe the clinical characteristics, management and outcomes of five SLE patients who developed severe left ventricular dysfunction. Four patients were female with mean age of 36.4 years. Three patients had both lupus myocarditis and lupus nephritis. Four patients had raised anti-dsDNA antibody titer and low complement level and two patients had positive IgG anticardiolipin antibody. Three patients were treated by high-dose corticosteroids, one patient by intravenous pulse methylprednisolone, and one patient by intravenous immunoglobulin and pulse cyclophosphamide with high dose corticosteroids. Left ventricular function improved markedly in four patients and all of them had no recurrence of lupus myocarditis up to follow-up of 33 months. However, one patient, who showed no improvement of left ventricular function, was expired due to sudden cardiac arrest. Lupus myocarditis should be treated by immunosuppressive therapy with high-dose corticosteroids and mostly the prognosis might be good with early treatment.
Tài liệu tham khảo
D’Cruz D, Khamashta M, Huges GRV (2001) Cardiovascular manifestation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematous. Lippincott Williams and Wilkins, Philadelphia pp 645
Kao AH, Manzi S (2002) How to manage patients with cardiopulmonary disease? Best Pract Res Clin Rheumatol 16:211–227
Wijetunga M, Rockson S (2002) Myocarditis in systemic lupus erythematosus. Am J Med 113:419–423
Moder KG, Miller TD, Tazelaar HD (1999) Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 74:275–284
Sasson Z, Rasooly Y, Chow CW, Marshall S, Urowitz MB (1992) Impairment of left ventricular diastolic function in systemic lupus erythematosus. Am J Cardiol 69:1629–1634
Cervera R, Font J, Pare C et al (1992) Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 51:156–159
Doherty NE, Siegel RJ (1985) Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110:1257–1265
Feldman AM, McNamara D (2000) Myocarditis. N Eng J Med 343:1388–1398
Murphy JG, Franz RP (2003) Endomyocardial biopsy in myocarditis. In: Cooper LT (Ed) Myocarditis: from bench to bedside. Humana, Totowa
Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kuhl U (2003) Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 3:127–135
Biadani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69:849–858
Logar D, Kveder T, Rozman B, Dovovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49:627–629
Leung WH, Wong KL, Lau CP, Wong CK, Liu HW (1990) Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 89:411–419
Comin-Colet J, Saches-Corral MA, Alegre-Sancho JJ, Valverde J, Lopez-Gomez D, Sabate X et al (2001) Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy. Lupus 10:59–62
Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental series. Lupus 14:827–831
Mason JW, O’Connel JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE (1995) For the myocarditis treatment trial investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Eng J Med 333:269–275
McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarcznk T, Kessler P, Mann DL, Feldman AM (2001) Controlled trial of intravenous immunoglobulin in recent-onset dialted cardiomyopathy. Circulation 103:2254–2259
Frustaci A, Gentiloni N, Caldarulo M (1996) Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 109:282–284
Chan YK, Li EK, Tam LS, Chow LT, Ng HK (2003) Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol 32:306–308
Naarendorp M, Kerr LD, Khan AS, Ornstein MH (1999) Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of six cases. J Rheumatol 26:2257–2260
Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238–240
Jacques E, Sophie R, Patrick A, Didier C, Xavier M (2004) Specific cardiomyopathy in lupus patients: report of three cases. Joint Bone Spine 71:66–69
Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri MA (2005) Cardiac involvement in systemic lupus erythematosus. Lupus 14:683–686
Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G et al (2004) Prolongation of the corrected QT intervals in adult patients with anti-Ro/SSA positive connective tissue diseases. Arthritis Rheum 50:1248–1252